“Alarming Rise” of Global MASH-Related Primary Liver Cancer Incidence Since 2000
Over the last 20 years, metabolic dysfunction–associated steatohepatitis (MASH) has been a partial driver of primary liver cancer (PLC), according to a review published in Clinical Gastroenterology and Hepatology.1 The investigators believe their decades-spanning analysis underscores the need to address access barriers to anti-obesity therapeutics | image credit: BillionsPhotos.com – stock.adobe.com Although MASH remains one … Read more